SAD BUT TRUE. Today’s treatments to kill cancer cells all too often damage normal cells. But a Stony Brook research team has been working on ways to prevent the growth of new blood vessels in tumors. The process is called antiangiogenesis…a long word that spells a potentially short life for tumors.